IRIS
CLEMENTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.788
AS - Asia 7.665
NA - Nord America 7.300
SA - Sud America 1.932
Continente sconosciuto - Info sul continente non disponibili 325
AF - Africa 150
OC - Oceania 16
Totale 25.176
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.921
RU - Federazione Russa 4.577
SG - Singapore 2.735
CN - Cina 2.488
BR - Brasile 1.576
SE - Svezia 1.093
HK - Hong Kong 969
IT - Italia 756
VN - Vietnam 734
FR - Francia 396
DE - Germania 296
CA - Canada 187
GB - Regno Unito 176
IN - India 163
BD - Bangladesh 152
FI - Finlandia 131
AR - Argentina 129
MX - Messico 76
EC - Ecuador 68
ID - Indonesia 65
PL - Polonia 63
IQ - Iraq 59
ZA - Sudafrica 55
ES - Italia 52
IE - Irlanda 52
AT - Austria 49
NL - Olanda 44
CO - Colombia 43
TR - Turchia 43
JP - Giappone 42
UZ - Uzbekistan 34
JM - Giamaica 31
PY - Paraguay 29
VE - Venezuela 28
SA - Arabia Saudita 26
MA - Marocco 24
PH - Filippine 23
PK - Pakistan 23
UA - Ucraina 23
CL - Cile 22
TN - Tunisia 18
LT - Lituania 16
PE - Perù 16
CR - Costa Rica 15
UY - Uruguay 15
MY - Malesia 14
AE - Emirati Arabi Uniti 13
JO - Giordania 12
RO - Romania 12
TT - Trinidad e Tobago 12
AU - Australia 11
DZ - Algeria 11
EG - Egitto 11
HN - Honduras 11
NI - Nicaragua 10
KE - Kenya 9
NP - Nepal 9
BE - Belgio 8
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
IL - Israele 6
SV - El Salvador 6
BB - Barbados 5
BH - Bahrain 5
BO - Bolivia 5
GA - Gabon 5
HU - Ungheria 5
IR - Iran 5
KZ - Kazakistan 5
MD - Moldavia 5
TH - Thailandia 5
AL - Albania 4
BG - Bulgaria 4
GR - Grecia 4
LB - Libano 4
NZ - Nuova Zelanda 4
SN - Senegal 4
BY - Bielorussia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
KW - Kuwait 3
MU - Mauritius 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
TW - Taiwan 3
BN - Brunei Darussalam 2
BS - Bahamas 2
GD - Grenada 2
GP - Guadalupe 2
HR - Croazia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 24.828
Salva come PNG Salva come JPEG
Città #
Singapore 1.118
Moscow 986
Hong Kong 960
San Jose 931
Dallas 894
Ashburn 860
Shanghai 474
Council Bluffs 413
Hefei 385
Princeton 361
Lawrence 356
Lauterbourg 328
Ho Chi Minh City 304
Beijing 283
Milan 260
New York 231
Hanoi 153
São Paulo 143
Los Angeles 137
Santa Clara 123
Helsinki 98
Phoenix 79
Munich 72
Nuremberg 68
Warsaw 60
Orem 57
Rome 54
Dublin 50
Seattle 48
Chennai 47
Atlanta 44
Denver 44
Montreal 44
Rio de Janeiro 43
Boston 41
Brasília 41
Toronto 41
London 40
Boardman 39
Pune 39
Johannesburg 37
Poplar 36
Tokyo 36
Brooklyn 34
Chicago 34
Stockholm 34
Belo Horizonte 33
Guangzhou 32
Tashkent 32
Da Nang 31
Bologna 30
Washington 30
Houston 28
Frankfurt am Main 27
Mexico City 26
Porto Alegre 25
Turku 25
Kingston 24
Quito 24
Brescia 23
Haiphong 23
Shenzhen 23
Guarulhos 21
Amsterdam 20
Ankara 20
Guayaquil 20
Hangzhou 20
Manchester 20
Tianjin 20
Vienna 20
Ancona 19
Biên Hòa 19
Falkenstein 18
Baghdad 17
Manaus 17
Salvador 17
Campinas 16
Miami 16
San Francisco 16
Cesano Boscone 15
Mumbai 15
Naples 15
Ribeirão Preto 15
Turin 15
The Dalles 14
Dhaka 13
Hải Dương 13
Las Vegas 13
Ninh Bình 13
Thái Bình 13
Asunción 12
Bogotá 12
Buenos Aires 12
Caxias do Sul 12
Columbus 12
Curitiba 12
Jakarta 12
Joinville 12
Miano 12
Montevideo 12
Totale 11.986
Salva come PNG Salva come JPEG
Nome #
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 240
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 215
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 188
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 186
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 157
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 155
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 154
Biobanking for COVID-19 research 151
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 147
The interferon landscape along the respiratory tract impacts the severity of COVID-19 147
A Biologically-validated HCV E1E2 Heterodimer Structural Model 139
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 137
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 136
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 136
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 136
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 135
Laparoscopic right hemicolectomy: the SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective trial on 1225 cases comparing intra corporeal versus extra corporeal ileo-colic side-to-side anastomosis 135
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 134
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 132
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 132
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 131
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 128
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 126
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 125
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 124
Characterization of GBV-C infection in HIV-1 infected patients 120
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 120
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 120
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 118
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 117
2-Aminothiazolones as Anti-HIV Agents That Act as gp120-CD4 Inhibitors 117
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 113
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 113
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 113
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 112
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 110
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 110
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 109
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 107
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 107
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection 106
A closer look at prion strains: Characterization and important implications 106
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 106
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 105
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 105
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 104
"Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3 104
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 103
Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group) 102
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 102
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 101
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 100
Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen 100
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 99
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 99
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 99
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 99
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 97
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 97
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 96
A SINGLE-STEP DNA EXTRACTION PROCEDURE FOR THE DETECTION OF SERUM HEPATITIS-B VIRUS SEQUENCES BY THE POLYMERASE CHAIN-REACTION 96
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 96
Three-row versus two-row circular staplers for left-sided colorectal anastomosis: a propensity score-matched analysis of the iCral 2 and 3 prospective cohorts 95
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 93
A NOVEL PROCEDURE FOR QUANTITATIVE POLYMERASE CHAIN-REACTION BY COAMPLIFICATION OF COMPETITIVE TEMPLATES 93
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 92
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 92
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis 91
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 91
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 90
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 90
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 90
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 89
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 89
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 88
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 86
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 85
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 85
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 84
Role and potential therapeutic use of antibodies against herpetic infections 83
Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota 82
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 82
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 82
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 82
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 82
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. 81
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 81
Viral Respiratory Pathogens and Lung Injury 81
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 81
HCV E2 core structures and mAbs: something is still missing 80
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption 79
Coronaviridae and SARS-associated coronavirus strain HSR1 79
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 78
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 76
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum 76
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 75
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 75
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection 74
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 74
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 73
Totale 10.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022203 0 0 0 72 19 18 15 15 12 18 8 26
2022/20231.989 811 463 167 18 26 224 71 112 71 5 13 8
2023/2024936 21 44 151 95 68 228 22 79 5 41 45 137
2024/20254.713 607 80 49 131 126 406 619 451 911 618 314 401
2025/202614.792 1.118 1.229 1.224 2.142 1.033 417 1.339 1.050 3.980 695 288 277
2026/20272.249 486 787 781 195 0 0 0 0 0 0 0 0
Totale 25.176